Fundraising Fox

Immunophotonics, Inc.

St. Louis, US · Founded 2012 · Delaware corporation · 4 known investors

immunophotonics.com ↗

Immunophotonics is a clinical-stage biotech company developing novel treatments for solid-tumor cancers and infectious diseases by combining tumor ablation with systemic cancer immunotherapy. The company's intellectual property platform includes IP-001, designed to transform routine ablation procedures into systemically active cancer immunotherapy.

BiotechDeep TechDigital HealthMedical Devicesin /immunophotonics-inc

Founders & leadership

DH
Dr. HodeCo-Founder & Senior Fellow
MA
Mr. AlleruzzoCo-Founder & Director
DC
Dr. ChenCo-Founder
DR
Dr. Robert NordquistCo-Founder
DS
David SmollerDirector
CB
Charlie BoltenDirector
BS
Bobby SandageDirector
PA
Peter A. JenkinsDirector

Investors · 4

BioGenerator VenturesSt. Louis · $50K – $250K
iSelect FundSt. Louis · $250K – $2M
Missouri Technology CorporationSt. Louis
Cultivation CapitalreportedSt. Louis · $100K – $3.5M

Reported raises · per SEC filings

Form D private placements
▶$1.5MraisedMar 2024 · 17 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Bobby W. SandageDirector
  • Wei R. ChenDirector, Promoter
  • Miguel ZubizarretaDirector
  • Charlie BoltenDirector
  • Tomas HodeExecutive Officer, Director, Promoter
  • Jonathan KnowlesDirector
  • Luciano AlleruzzoExecutive Officer, Director, Promoter
Offering amount
$4M
Amount sold
$1.5M
Minimum investment
$25K
First sale
Feb 2024
Incorporated
Corporation, Delaware
Federal exemptions
04, 06b
Full filing on SEC EDGAR ↗
▶$3.5MraisedFeb 2023 · 22 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Luciano AlleruzzoExecutive Officer, Director, Promoter
  • Tomas HodeExecutive Officer, Director, Promoter
  • Jonathan KnowlesDirector
  • Miguel ZubizarretaDirector
  • Charlie BoltenDirector
  • Wei R. ChenDirector, Promoter
  • Bobby W. SandageDirector
Offering amount
$6.5M
Amount sold
$3.5M
Minimum investment
$50K
First sale
Jan 2023
Incorporated
Corporation, Delaware
Federal exemptions
04, 06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedJan 2015 · 28 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David SmollerDirector
  • Charlie BoltenDirector
  • Tomas HodeExecutive Officer, Director
  • Bobby SandageDirector
  • Robert E. NordquistDirector
  • Lu AlleruzzoExecutive Officer
  • Wei R. ChenDirector
  • Peter A. JenkinsDirector
Offering amount
$3.4M
Amount sold
$2.5M
First sale
Jun 2014
Incorporated
Corporation, Wyoming, 2012
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news